Can you explain cerebral contusions, including their definition, classification as hemorrhagic or non‑hemorrhagic, coup and countercoup mechanisms, radiologic features on non‑contrast CT with Hounsfield unit values, MRI characteristics, and how imaging appearance evolves over time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Cerebral Contusions: Comprehensive Overview

Definition

Cerebral contusions are focal traumatic brain injuries characterized by bruising of brain parenchyma with associated hemorrhage, edema, and necrosis, representing one of the most clinically significant parenchymal lesions in traumatic brain injury. 1

Classification by Hemorrhagic Content

Hemorrhagic Contusions

  • Contain visible blood products with macroscopic hemorrhage
  • More readily detected on initial CT imaging
  • Associated with worse outcomes when volume exceeds critical thresholds

Non-hemorrhagic Contusions

  • Lack macroscopic hemorrhage initially
  • Represent >80% of diffuse axonal injury lesions 2
  • Often invisible on CT but detectable on MRI
  • May evolve into hemorrhagic lesions over time

Mechanism of Injury: Coup vs. Contrecoup

Coup Injuries (66% of contusions) 3

  • Occur directly at the site of impact
  • Result from direct mechanical deformation of skull and underlying brain
  • Associated with skull fractures in 54% of cases 3
  • Typically involve frontal and temporal lobes at impact site

Contrecoup Injuries

  • Occur opposite to the site of impact
  • Mechanism involves rotational acceleration forces, intracranial pressure gradients, and skull deformation—NOT simple rebound forces 4
  • Represent secondary traumatic lesions with hemangiopathic and ischemic components 5
  • Progress or regress based on cerebral blood flow changes and vascular wall integrity 5
  • Frontal and temporal lobes most commonly involved 4
  • Contrecoup-related subarachnoid hemorrhage is exceedingly rare 6

Critical Pitfall: Contrecoup injuries should be considered secondary traumatic lesions rather than simple contusions, as they have distinct hemangiopathic and ischemic pathophysiology 5

Radiologic Features on Non-Contrast CT

Hemorrhagic Contusions

Acute Phase (0-24 hours)

  • Hounsfield Units: 50-90 HU (acute blood)
  • Hyperdense (bright) focal lesions
  • Most commonly in inferior, lateral, and anterior aspects of frontal and temporal lobes 7
  • May show heterogeneous density with mixed blood and edema

Evolution Over Time (HU Values)

Based on 8, which evaluated 666 patients:

  • First 2 hours: Highest HU values (60-90 HU)
  • 2-6 hours: HU values begin to decrease
  • 6-12 hours: Progressive decrease continues
  • 12-24 hours: Further decline in density
  • 24-48 hours: Continued decrease
  • 48-96 hours: Lowest HU values as blood products break down

Key Finding: The heterogeneity index (range between lowest and highest HU values within same lesion) increases over time in extra-axial hematomas 8. In intra-axial hemorrhages, the central portion shows the slowest decrease in HU values 8.

Critical Clinical Point: Evaluating only volumetric increase is insufficient—HU value measurements provide quantitative data about bleeding time and can identify new bleeding 8

Non-hemorrhagic Contusions

  • Often invisible or very subtle on CT
  • May appear as ill-defined areas of low attenuation (edema)
  • HU values: 20-30 HU (similar to edema)
  • CT insensitive to detection of smaller non-hemorrhagic contusions 9

MRI Features and Temporal Evolution

Hemorrhagic Contusions

MRI is superior to CT for detecting all stages of contusions 9

Acute Phase (0-3 days)

  • T1-weighted: Isointense to hypointense
  • T2-weighted: Hypointense (deoxyhemoglobin)
  • T2 GRE/SWI:* Markedly hypointense (blooming artifact)
  • DWI: Hyperintense (restricted diffusion)
  • FLAIR: Hyperintense surrounding edema

Early Subacute (3-7 days)

  • T1-weighted: Hyperintense rim (methemoglobin)
  • T2-weighted: Hypointense center, hyperintense rim
  • T2 GRE/SWI:* Hypointense (very sensitive)
  • Acute blood may distort typical appearance 10

Late Subacute (1-4 weeks)

  • T1-weighted: Hyperintense throughout
  • T2-weighted: Hyperintense
  • Enhancement: Subacute contusions enhance due to blood-brain barrier disruption and inflammation 9
  • Repeat MRI after acute blood resolves reveals underlying lesion 10

Chronic (>4 weeks)

  • Hemosiderin ring: T2 hypointense rim on all sequences
  • Central cavity: T1 and T2 hyperintense (encephalomalacia)
  • T2 GRE/SWI:* Persistent hypointense hemosiderin deposition
  • May show focal encephalomalacia at inferior frontal or anterior temporal lobes 2

Non-hemorrhagic Contusions

Acute Phase

  • T2-weighted/FLAIR: Hyperintense (more sensitive than CT) 9
  • DWI: Hyperintense with restricted diffusion
  • T1-weighted: Hypointense
  • T2 GRE:* No blooming artifact (distinguishes from hemorrhagic)

Subacute to Chronic

  • Progressive gliosis and encephalomalacia
  • T2/FLAIR hyperintensity persists
  • Volume loss develops over time

Key MRI Sequences and Their Utility

T2-weighted and FLAIR

  • More sensitive than CT for detecting subacute subarachnoid hemorrhage, small subdural hematomas, brain contusions, and brainstem injuries 9
  • Comparable to or more sensitive than CT for all stages of subarachnoid hemorrhage 9

T2* GRE

  • Equivalent to CT for acute intracranial hemorrhage 9
  • Significantly more sensitive than CT for subacute and chronic hemorrhage 9
  • Very sensitive to microhemorrhages 9

Susceptibility-Weighted Imaging (SWI)

  • 3-6 times more sensitive than T2 GRE for detecting hemorrhagic axonal injuries* 9
  • Extremely sensitive for depicting intracranial blood products of various stages 9
  • Uses both magnitude and phase data to improve contrast 9

Diffusion-Weighted Imaging (DWI)

  • Sensitive to acute parenchymal contusions 9
  • Permits visualization of axonal injuries and fat emboli not seen on FLAIR or T2* GRE 9

Clinical Imaging Algorithm

Acute Setting (0-24 hours)

  1. Non-contrast CT is first-line imaging (Class I recommendation) 9
  2. If CT normal but persistent unexplained neurologic findings exist, perform MRI (Class I recommendation) 9

Subacute/Chronic Setting (>7 days)

  1. MRI is preferred initial imaging 2
  2. More sensitive for subtle findings, microbleeds, and chronic sequelae
  3. CT valid only for specific questions not requiring high soft-tissue resolution 2

Contrast Administration

  • No scientific evidence supports routine gadolinium use in acute TBI (Class IIb recommendation) 9
  • Contrast does not improve conspicuity of acute injury 9
  • May show enhancement in subacute stages (1-4 weeks) due to blood-brain barrier disruption 9

Critical Prognostic Factors

Contusion volume is significantly associated with Glasgow Outcome Scale (r=-0.760, p<0.001) and mortality 3. Large volume, herniation-type appearance, and unfavorable anatomical location predict poor functional outcome and in-hospital mortality 3.

Common Pitfall: Radiological follow-up should not rely solely on volumetric assessment—HU value measurements and heterogeneity index provide critical information about ongoing bleeding 8.

References

2
Guideline

acr appropriateness criteria® head trauma: 2021 update.

Journal of the American College of Radiology, 2021

Related Questions

What is the definition of contusio cerebri (cerebral contusion) and its pathophysiological mechanism?
For a patient who had an isolated traumatic subarachnoid hemorrhage and has been stable for five years, is any routine imaging or continued neurosurgical follow‑up required?
For a patient who had a sudden fall resulting in frontal intracranial hemorrhage with thick dark coagulated blood and hypertension (BP 160/100 mmHg), should I obtain an emergent non‑contrast CT or MRI to guide further management?
What is the recommended follow‑up protocol for a patient with traumatic subarachnoid hemorrhage after head injury?
Which of gabapentin, Buspar (buspirone), Lexapro (escitalopram), or Wellbutrin (bupropion) is causing the patient's recent severe headaches?
Are there any contraindications or drug interactions when adding hydroxyzine to a patient currently taking carbamazepine and gabapentin?
What is the recommended dosing regimen of secukinumab (Cosentyx) for an adult with psoriatic arthritis, including weight‑based dosing and options for severe disease?
How many weeks should a patient wait before starting secukinumab after switching from Cimzia (certolizumab pegol)?
What is the recommended dosing and administration of midazolam for rapid sedation in a severely injured, markedly agitated patient?
What additional medications can be used to target borderline personality disorder symptoms that have not improved with an SSRI or SNRI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.